192 related articles for article (PubMed ID: 36266306)
1. Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy.
He G; Li Y; Younis MR; Fu LH; He T; Lei S; Lin J; Huang P
Nat Commun; 2022 Oct; 13(1):6238. PubMed ID: 36266306
[TBL] [Abstract][Full Text] [Related]
2. Relationship of delta-aminolevulinic acid-induced protoporphyrin IX levels to mitochondrial content in neoplastic cells in vitro.
Gibson SL; Nguyen ML; Havens JJ; Barbarin A; Hilf R
Biochem Biophys Res Commun; 1999 Nov; 265(2):315-21. PubMed ID: 10558864
[TBL] [Abstract][Full Text] [Related]
3. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
[TBL] [Abstract][Full Text] [Related]
5. Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell lung cancer and metastatic brain tumor specimens originating from non-small cell lung cancer.
Omoto K; Matsuda R; Nakai Y; Tatsumi Y; Nakazawa T; Tanaka Y; Shida Y; Murakami T; Nishimura F; Nakagawa I; Motoyama Y; Nakamura M; Fujimoto K; Hiroyuki N
Photodiagnosis Photodyn Ther; 2019 Mar; 25():309-316. PubMed ID: 30639584
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
7. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
8. Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer.
Nakai Y; Tatsumi Y; Miyake M; Anai S; Kuwada M; Onishi S; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
Photodiagnosis Photodyn Ther; 2016 Mar; 13():225-232. PubMed ID: 26226642
[TBL] [Abstract][Full Text] [Related]
9. Alectinib treatment improves photodynamic therapy in cancer cell lines of different origin.
Gillissen B; Richter A; Essmann F; Kemmner W
BMC Cancer; 2021 Aug; 21(1):971. PubMed ID: 34461853
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.
Harada Y; Murayama Y; Takamatsu T; Otsuji E; Tanaka H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742921
[TBL] [Abstract][Full Text] [Related]
11. Quinolone compounds enhance delta-aminolevulinic acid-induced accumulation of protoporphyrin IX and photosensitivity of tumour cells.
Ohgari Y; Miyata Y; Chau TT; Kitajima S; Adachi Y; Taketani S
J Biochem; 2011 Feb; 149(2):153-60. PubMed ID: 20961864
[TBL] [Abstract][Full Text] [Related]
12. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy.
De Rosa FS; Marchetti JM; Thomazini JA; Tedesco AC; Bentley MV
J Control Release; 2000 Apr; 65(3):359-66. PubMed ID: 10699294
[TBL] [Abstract][Full Text] [Related]
13. Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis.
Lai HW; Nakayama T; Ogura SI
Int J Clin Oncol; 2021 Jan; 26(1):26-33. PubMed ID: 32875514
[TBL] [Abstract][Full Text] [Related]
14. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
16. Targeting of sebocytes by aminolevulinic acid-dependent photosensitization.
Kosaka S; Kawana S; Zouboulis CC; Hasan T; Ortel B
Photochem Photobiol; 2006; 82(2):453-7. PubMed ID: 16613498
[TBL] [Abstract][Full Text] [Related]
17. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
[TBL] [Abstract][Full Text] [Related]
18. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines.
Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H
Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837
[TBL] [Abstract][Full Text] [Related]
19. Effect of estrogenic perturbations on delta-aminolevulinic acid-induced porphobilinogen deaminase and protoporphyrin IX levels in rat Harderian glands, liver, and R3230AC tumors.
Gibson SL; Anderson LT; Havens JJ; Hilf R
Biochem Pharmacol; 1999 Dec; 58(11):1821-9. PubMed ID: 10571258
[TBL] [Abstract][Full Text] [Related]
20. Imaging of hypoxia, oxygen consumption and recovery in vivo during ALA-photodynamic therapy using delayed fluorescence of Protoporphyrin IX.
Scholz M; Petusseau AF; Gunn JR; Shane Chapman M; Pogue BW
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101790. PubMed ID: 32344195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
